Clinical Trials Logo

Clinical Trial Summary

To demonstrate the efficacy, therapeutic equivalence and safety of Ketoconazole Shampoo, 2% (Taro Pharmaceuticals U.S.A., Inc.) and Ketoconazole 2% Shampoo (Reference Standard) in the treatment of tinea versicolor.


Clinical Trial Description

A multi-center, double-blind, randomized, placebo controlled, parallel-group study, comparing Ketoconazole Shampoo, 2% (Taro Pharmaceuticals U.S.A, Inc.) to Ketoconazole Shampoo, 2% (Reference Standard) and both active treatments to a placebo control in the treatment of tinea versicolor. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06305637
Study type Interventional
Source Taro Pharmaceuticals USA
Contact
Status Completed
Phase Phase 1
Start date December 4, 2023
Completion date February 10, 2024

See also
  Status Clinical Trial Phase
Completed NCT00830388 - Ketoconazole Foam 2% for the Treatment of Versicolor Phase 4
Completed NCT04937920 - A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor Phase 2
Completed NCT05862714 - Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor Phase 1
Not yet recruiting NCT05730244 - A Study of the Clinical Efficacy and Safety of 100% Cassia Alata Extract Against Tinea Versicolor Phase 1
Completed NCT04110860 - Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel Phase 2
Completed NCT04110834 - Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel Phase 2